T. Rowe Price Investment Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
NAMI
B
T. Rowe Price Investment Management's NEO Position: Q2 2026 in Review
T. Rowe Price Investment Management opened a new position in NeoGenomics (NEO) in Q2 2026: 1,216,358 shares worth $17.7M. The stake represents 0.01% of the portfolio and ranks #559 among its holdings. This is a return to the name: T. Rowe Price Investment Management previously reported a position in NEO as recently as Q4 2025.
T. Rowe Price Investment Management first reported a position in NEO in Q3 2022 and has held it in 15 quarters since. The position peaked at $108M in Q1 2024. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- T. Rowe Price Investment Management held 1,216,358 shares of NeoGenomics worth $17.7M as of Q2 2026.
- NeoGenomics was a new T. Rowe Price Investment Management position in Q2 2026.
- NeoGenomics made up 0.01% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #559 holding.
- T. Rowe Price Investment Management first reported a position in NeoGenomics in Q3 2022 and has held it in 15 quarters since.
- T. Rowe Price Investment Management's NeoGenomics position peaked at $108M in Q1 2024.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.